Siemens Healthcare unveiled this week new cardiac imaging software, dubbed syngo Dynamic PET with Myocardial Blood Flow, for its Biograph PET/CT scanners
Siemens unveils coronary PET/CT software
Siemens Healthcare unveiled this week new cardiac imaging software, dubbed syngo Dynamic PET with Myocardial Blood Flow, for its Biograph PET/CT scanners. The new FDA-cleared product, introduced at the American Society for Nuclear Cardiology Scientific Session in Minneapolis, offers a new method for quantitatively evaluating the extent of ischemia via high-performance PET/CT imaging and advanced applications, according to Siemens. Syngo Dynamic PET may have a significant impact on the diagnosis of patients with advanced coronary artery disease, particularly those with multi-vessel disease, or those who are asymptomatic, the company said. Published clinical literature estimates that between 5% and 10% of coronary artery disease patients have balanced vessel disease, and up to 8% are at-risk but asymptomatic. Siemens’ new product may be most valuable to this high-risk group.
What a New Meta-Analysis Reveals About PET/CT Radiotracers for csPCa
February 6th 2025The PET/CT agent 18F-PSMA-1007 offered the highest surface under the cumulative ranking curve (SUCRA) out of nine radiotracers at the patient and lesion level for detecting clinically significant prostate cancer (csPCa), according to a meta-analysis.
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.